The medication has demonstrated significant efficacy in clinical trials, with patients achieving meaningful reductions in HbA1c levels and body weight
Read our guide on 503B compounding pharmacies and tirzepatide for regulatory details
The 503A facilities also are producing compounded semaglutide and tirzepatide for hundreds of thousands of patients
Third-party tested and 99% purity confirmed by in-house HPLC
Mechanism of action CJC-1295 acts through the GHRH receptor on anterior pituitary somatotrophs, the same target as sermorelin and endogenous GHRH
The most serious side effects of GLP-1 receptor agonists include gallbladder problems, pancreatitis, acute kidney damage, gastroparesis, bowel obstruction, and intestinal paralysis